Healthcare Changes Under Biden: The Shift You Might Have Missed
- 01. Healthcare changes under Biden: what's quietly different now
- 02. Core pillars of Biden-era healthcare policy
- 03. ACA subsidies, enrollment, and the "family glitch"
- 04. Medicaid expansion and state incentives
- 05. Drug pricing and Medicare reforms
- 06. Surprise billing, price transparency, and network rules
- 07. Protecting pre-existing conditions and "junk" plans
- 08. Behavioral health, telehealth, and rural access
- 09. Health savings accounts and plan design shifts
- 10. Political pushback and looming subsidy cliffs
- 11. Key statistics at a glance
- 12. What's different for people with pre-existing conditions?
Healthcare changes under Biden: what's quietly different now
Under the Biden administration, the U.S. healthcare system has quietly shifted toward expanded coverage, tighter drug-pricing rules, and stronger protections for people with pre-existing conditions, even as the basic structure of the Affordable Care Act remains intact. Since 2021, President Biden has used a mix of executive actions, new regulations, and major legislation-such as the Inflation Reduction Act-to push down Medicare drug prices, extend ACA subsidies, and curb surprise medical bills. These changes have already altered how millions of Americans choose insurance, pay for prescriptions, and transition between Medicaid and marketplace plans, especially in states that have expanded Medicaid under his policy incentives.
Core pillars of Biden-era healthcare policy
The Biden administration has organized its healthcare agenda around three overlapping goals: expanding coverage, squeezing provider and drug costs, and tightening guardrails around "junk" insurance. From day one, the White House signaled that preserving and strengthening the Affordable Care Act would be the centerpiece, reversing Trump-era efforts to weaken the law through regulatory changes and court threats. Instead of trying to override the ACA with a single "Medicare for All" bill, Biden has leaned on executive authority, rulemaking, and targeted statutes to nudge the system toward lower premiums, more enrollees, and fewer surprise bills.
To achieve this, the administration has leaned heavily on the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) to reinterpret eligibility rules, extend special enrollment periods, and codify consumer protections. For example, CMS has broadened the circumstances under which people can enroll in marketplace plans outside the annual open-enrollment window, and HHS has tightened rules around short-term, limited-duration plans that often exclude coverage for pre-existing conditions. These regulatory tweaks, while less visible than headline legislation, have quietly widened the number of Americans who can qualify for subsidized coverage without triggering an insurance gap.
ACA subsidies, enrollment, and the "family glitch"
One of the most concrete changes under the Biden administration has been the extension and enhancement of ACA premium tax credits. The American Rescue Plan Act of 2021 temporarily raised the generosity of these credits and expanded eligibility to higher income levels, and the Inflation Reduction Act of 2022 locked those improvements in through 2025. By early 2025, nearly 24 million enrollees had signed up for marketplace plans, up from about 14 million when Biden took office, with roughly 80 percent of them paying $10 or less per month after subsidies.
Administration officials have also attacked the notorious "family glitch" through a combination of rulemaking and targeted legislation. That loophole previously left many employees' families uninsured when employer coverage met federal affordability standards for the worker but not for dependents. In 2023, the Treasury and HHS finalized a fix that allows family members to qualify for premium tax credits if their share of the employer's premium exceeds 8.37 percent of household income, a move analysts estimate has extended subsidized coverage to hundreds of thousands of previously ineligible people.
Since 2021, the federal government has also invested heavily in outreach, enrollment assistance, and navigator programs that were defunded under the previous administration. These efforts helped lift the uninsured rate for non-elderly adults to roughly 9.4 percent in 2023, down from about 11.5 percent in 2019, according to analyses from the Urban Institute and the Kaiser Family Foundation. That decline is especially pronounced among younger adults and people of color, who have historically been more likely to fall into coverage gaps.
Medicaid expansion and state incentives
Another major lever the Biden administration has used is Medicaid expansion through new federal incentives and waivers. The Families First Coronavirus Response Act (2020) and subsequent guidance tied enhanced federal matching rates to states that fully expanded Medicaid under the ACA, and Biden has preserved and reinforced those conditions. By late 2024, only 10 states had not adopted full expansion, down from 14 in 2020, with several Republican-led states-such as Missouri and Oklahoma-moving to expand after ballot initiatives.
In 2023, the administration issued additional guidance that made it easier for states to transition people from Medicaid to subsidized marketplace coverage without triggering insurance gaps, especially during the complex "unwinding" of the continuous enrollment period. CMS also created demonstration projects that allow states to test integrated delivery models linking Medicaid, Medicare, and marketplace plans, which has quietly encouraged more coordinated care for dual-eligible and low-income enrollees.
- Expansion incentives have helped reduce the number of Americans in the Medicaid coverage gap by roughly 30 percent since 2020.
- States that expanded Medicaid under Biden-era policies saw average uninsured rates drop from around 12 percent to under 7 percent by 2024.
- New CMS rules allow smoother transitions from Medicaid to marketplace plans for people whose incomes rise above traditional Medicaid thresholds.
Drug pricing and Medicare reforms
The most structurally significant Biden-era change is the introduction of limited Medicare drug price negotiations under the Inflation Reduction Act. For the first time, the federal government can directly negotiate prices for a small basket of high-cost drugs used by Medicare Part D and Medicare Advantage beneficiaries, with the first set of negotiated prices taking effect in 2026. The Biden administration estimates that these measures will reduce Medicare spending on the selected drugs by roughly 40-50 percent over the first decade, while capping out-of-pocket drug costs at $2,000 per year for Medicare enrollees starting in 2025.
Analysts at the Center on Budget and Policy Priorities have projected that the combined effect of price caps, inflation rebates, and the new negotiation authority could reduce aggregate Medicare prescription-spending growth by about 15-20 percent between 2023 and 2030, compared with a scenario where no Biden-era changes were enacted. These reforms do not replace private insurance markets, but they have materially reshaped the Medicare Advantage and Part D landscapes, forcing plans to reprice premiums and adjust benefit designs in response to the new cost-caps.
Beyond Medicare, the administration has strengthened the 340B drug-pricing program, which requires drug manufacturers to provide discounts to safety-net hospitals and clinics serving vulnerable populations. New oversight rules and audits have been introduced to curb abuses and ensure that 340B discounts are actually passed through to low-income patients, and the Biden administration has tentatively floated ideas for expanding 340B eligibility to additional community health centers. These steps have not revolutionized the entire pharmaceutical market, but they have given safety-net providers more leverage in contract negotiations and helped stabilize access in rural and underserved urban areas.
Surprise billing, price transparency, and network rules
To protect consumers from financial shocks, the Biden administration has codified and reinforced the federal ban on surprise medical bills that took effect in January 2022. Under the No Surprises Act, patients who receive emergency care or certain non-emergency services from out-of-network providers at in-network facilities are shielded from balance billing, and disputes are resolved through an independent arbitration process. Early data from the Department of Labor and CMS suggest that surprise-bill complaints have dropped by roughly 40-50 percent since the law's implementation, though some states have pushed for even stricter rules.
The administration has also used the price-transparency rules established during the Trump era and expanded them to require hospitals and insurers to publish standardized data on negotiated rates and historical charges. Although full compliance has been uneven, the increased data availability has empowered employers, unions, and a handful of state regulators to negotiate more aggressively with provider systems. In parallel, CMS has tightened rules around "surprise" ancillary services-such as radiology or anesthesia-by requiring clearer patient notifications and limiting out-of-network billing for certain scheduled procedures.
On the network-design side, the federal government has worked with states to tighten oversight of narrow-network plans that may technically comply with ACA standards but leave patients scrambling to find in-network providers. CMS has issued guidance that clarifies access standards and requires issuers to demonstrate that beneficiaries can realistically reach in-network hospitals and primary-care providers within defined time and distance thresholds. These changes are subtle but have already nudged several insurers to adjust their networks or add more specialists in key specialties such as oncology and behavioral health.
Protecting pre-existing conditions and "junk" plans
Ensuring that people cannot be denied coverage because of a pre-existing condition has been a cornerstone of the Biden administration's messaging and policy design. Beyond reaffirming the ACA's core protections, the administration has issued new rules limiting the duration of short-term, limited-duration insurance (STLDI) plans and association health plans, which often lack essential health benefits and can exclude people with chronic conditions. Current guidance caps STLDI initial terms at three months and limits extensions, effectively shrinking the pool of people who could be steered into bare-bones coverage that does not count as minimum essential coverage.
Regulators have also strengthened enforcement of the ACA's essential health benefits requirements, requiring issuers to document how their benefit designs meet minimum standards for hospitalization, prescription drugs, mental health, and maternity care. These rules make it harder for carriers to subtly narrow coverage through high cost-sharing or narrow provider networks without triggering CMS review. Consumer advocates estimate that these changes have reduced the number of truly "junk" plans on state and federal exchanges by more than half since 2020, though some loophole-exploiting products persist in the private-market ecosystem.
Behavioral health, telehealth, and rural access
The Biden administration has quietly reoriented several federal health programs to prioritize behavioral health and telehealth access. During the pandemic, CMS extended temporary telehealth flexibilities that allowed Medicare beneficiaries to receive many mental-health and chronic-care services remotely, and the administration has sought to make many of those flexibilities permanent. By 2024, over 60 percent of Medicare telehealth claims were for behavioral-health services, and similar trends have appeared in commercial and Medicaid programs.
In rural areas, the administration has tied additional federal funding to telehealth-enabled primary-care collaborations, rural health clinics, and federally qualified health centers (FQHCs). These investments have supported the expansion of Hub-and-Spoke models for treating opioid-use disorder and other substance-use conditions, and they have helped stabilize several rural hospitals that were on the brink of closure. Independent analyses suggest that rural uninsured rates have declined by about 1.5-2 percentage points since 2020, in part due to Medicaid expansion and telehealth-driven expansions of primary care.
- The federal government extended Medicare telehealth flexibilities through 2024 and is working to codify permanent coverage for many remote services.
- New funding rules require rural health clinics to demonstrate improved telehealth capacity to qualify for certain grants.
- The Biden administration has expanded mobile crisis and community-based behavioral-health programs, contributing to a roughly 10 percent increase in treatment access in targeted regions by 2024.
Health savings accounts and plan design shifts
For consumers who remain in the individual market, the Biden administration has overseen several plan-design changes that affect how people use health savings accounts (HSAs). Starting in 2026, federal guidance expands the number of high-deductible health plans that can be paired with HSAs, including all Bronze and Catastrophic marketplace plans that meet the statutory criteria. This change broadens the pool of enrollees who can combine tax-advantaged savings with lower premiums, particularly for younger and lower-income consumers who may otherwise face affordability barriers.
The administration has also introduced a new hardship exemption that expands eligibility for Catastrophic plans to individuals who are not eligible for savings on Marketplace coverage due to their income, provided those plans are offered in their area. This tweak is small but meaningful for people whose incomes are just above ACA subsidy thresholds yet still struggle to afford premiums, and it has been quietly absorbed into the broader fabric of the ACA marketplace rules.
Political pushback and looming subsidy cliffs
Not all of the Biden administration's healthcare changes have been universally welcomed. In 2025, the expiration of enhanced ACA premium tax credits triggered warnings from budget analysts and health-policy think tanks that millions of enrollees could face premium spikes or drop out of coverage. The Center on Budget and Policy Priorities estimated that without an extension, roughly 7.3 million people would lose subsidized coverage and several million more could become uninsured, with the heaviest impact in states that have not expanded Medicaid.
Several Republican-led states have also challenged the administration's moves on Medicaid work requirements, short-term plans, and surprise-billing rules in court, arguing that some federal actions overreach statutory authority. These legal battles have led to uneven enforcement and patchwork implementation, especially around the "family glitch" fix and the rules governing Medicaid unwinding. As of 2025, the future of many Biden-era healthcare provisions remains tied to congressional negotiations, which could reshape the Affordable Care Act framework again in the coming years.
Key statistics at a glance
| Policy area | Change under Biden | Estimated impact |
|---|---|---|
| ACA marketplace enrollment | Expanded subsidies and outreach | From ~14 million in 2021 to nearly 24 million in 2025 |
| Medicaid expansion | Enhanced incentives and waivers | Number of non-expansion states cut from 14 to 10 by 2024 |
| Medicare drug costs | Price caps and negotiation | Up to $2,000 annual cap on out-of-pocket drug spending by 2025 |
| Surprise medical bills | No Surprises Act enforcement | 30-40 percent decline in reported surprise-bill complaints |
| Rural uninsured rate | Medicaid expansion and telehealth investments | About 1.5-2 percentage-point drop since 2020 |
What's different for people with pre-existing conditions?
The Biden administration has reaffirmed and reinforced the ACA's core protections against discrimination based on pre-existing conditions, while tightening rules around short-term, limited-duration plans and association health plans that might exclude such conditions. New guidance limits the duration of these plans and strengthens enforcement of essential-health-benefits requirements, which has reduced the availability of "junk" plans that do not offer meaningful coverage for
Key concerns and solutions for Healthcare Changes Under Biden The Shift You Might Have Missed
How have ACA subsidies changed under Biden?
The Biden administration significantly expanded and extended ACA premium tax credits through the American Rescue Plan Act of 2021 and the Inflation Reduction Act of 2022. These laws made subsidies more generous, eliminated the 400 percent of federal poverty level income cap on eligibility, and locked the enhanced credits in through 2025. As a result, millions of enrollees pay $10 or less per month for coverage, and the uninsured rate among non-elderly adults has fallen by roughly two percentage points since 2020.
What has Biden done about surprise medical bills?
Under Biden's guidance, the federal government implemented the No Surprises Act, which took effect in January 2022 and prohibits unexpected balance billing for emergency services and certain non-emergency care in in-network facilities. The law requires insurers and providers to resolve payment disputes through an independent dispute resolution process, and early data show a substantial drop in surprise-bill complaints and large-dollar balance bills received by patients.
Has Biden expanded Medicare drug-price negotiations?
Yes. The Inflation Reduction Act authorizes the CMS to negotiate prices for a limited number of high-cost Medicare Part D and Medicare Advantage drugs, with the first negotiated prices scheduled to take effect in 2026. The administration estimates that these measures will reduce Medicare drug spending by 15-20 percent over the first decade and cap annual out-of-pocket drug costs at $2,000 for Medicare enrollees, starting in 2025.